Member Log-in

I forgot my password

Not a Member? Register

Rotavirus Vaccination is Cost Effective and Saves Lives, New Analysis Finds

In an analysis published in the December issue of The Lancet Global Health, investigators from PATH, the London School of Hygiene & Tropical Medicine, and the US Centers for Disease Control and Prevention, analyzed the potential costs of rotavirus vaccination for 10 successive birth cohorts (from 2018 through 2027) in 73 countries eligible for Gavi support, compared with no vaccination.  The analysis found that over the 10-year study period, rotavirus vaccination would prevent nearly 600,000 deaths in Gavi-eligible countries. Governments in these countries would save nearly $500 million through the elimination of some of the more than 80 million outpatient health care provider visits and nearly 8 million hospitalizations that would be required to treat those sickened by rotaviruses.

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Please Help WHO, UNICEF, Gavi and the Boost Immunization Professional Community Understand Your Needs During COVID-19 Pandemic

You are most certainly getting many questions on COVID-19. Technical guidance has been developed on how to maintain safe immunization services, advice on campaigns and how to plan for catch-up vaccination after the pandemic, but the situation is evolving. We need your assistance to better understand what you need from WHO, UNICEF, Gavi and the … Continued

Materials from Immunization Economics’ 2019 iHEA Pre-Congress Session Now Available

As part of the 2019 iHEA biennial world congress in Basel, Switzerland, the Immunization Economics Special Interest Group (SIG) organized a pre-congress session on July 13-14. The program, which focused on the generation and use of information surrounding immunization costing, financing, and value of vaccination, included: Featured updates on research findings, methodology, and cases; Concurrent … Continued

Continuing Pneumococcal Vaccination After Gavi Transition in Kenya at Full Price is Cost-effective and Could Save Thousands of Lives

This news release was originally published on EurekAlert. Below is an excerpt from the news release. Co-led by the London School of Hygiene & Tropical Medicine and the KEMRI-Wellcome Trust Research Program, the Pneumococcal Conjugate Vaccine Impact Study estimated that continuing the vaccine beyond 2022 would prevent – in the first ten years – more than … Continued

Choose a Language